Core Viewpoint - Zai Ding Pharmaceutical (09688) announced the grant of stock options and restricted stock units as part of its 2024 equity incentive plan, indicating a focus on employee retention and motivation through equity compensation [1] Summary by Category Stock Options - The company granted stock options to one grantee for a total of 25,000 American Depositary Shares (ADS) [1] Restricted Stock Units - Additionally, the company awarded restricted stock units to seven grantees involving a total of 32,200 ADS [1]

Core Viewpoint - BeiGene (06160) announced that a total of 63,000 American Depositary Shares (ADS) will be purchased by 3,932 participants under the 2018 Employee Stock Purchase Plan during the subscription period from March 3, 2025, to August 29, 2025, representing approximately 0.05% of the company's total issued shares as of the announcement date [1] Summary by Relevant Sections - **Subscription Details** - The subscription period for the purchase of ADS is set from March 3, 2025, to August 29, 2025 [1] - A total of 63,000 ADS will be acquired by 3,932 participants [1] - **Share Representation** - The number of shares involved in the purchase amounts to 818,500 [1] - This represents about 0.05% of the total issued shares of the company as of the announcement date [1]

Core Viewpoint - BeiGene (06160.HK) announced that a total of 62,962 American Depositary Shares (ADS) were purchased by 3,932 participants under the 2018 Employee Stock Purchase Plan during the subscription period from March 3, 2025, to August 29, 2025, representing approximately 0.05% of the company's total issued shares as of the announcement date [1]. Summary by Category - **Company Actions** - The company reported the purchase of 62,962 ADS by employees, indicating active participation in the employee stock purchase plan [1]. - The total number of shares involved in the purchase is 818,506 [1]. - **Financial Impact** - The purchased ADS represents about 0.05% of the total issued shares of the company as of the announcement date [1].

Core Viewpoint - The announcement from BeiGene indicates that a total of 3,932 participants purchased 62,962 American Depositary Shares (ADS) under the 2018 Employee Stock Purchase Plan, representing approximately 0.05% of the company's total issued shares [1] Summary by Relevant Sections - **Employee Participation**: A total of 3,932 participants engaged in the stock purchase plan [1] - **Shares Purchased**: Participants acquired 62,962 ADS, which corresponds to 81.85 million shares [1] - **Share Price**: The price per ADS was set at $208.7, equating to approximately HKD 125.06 per ordinary share [1] - **Total Amount Deducted**: The authorized salary deduction amount during the subscription period was $13.4495 million [1]

Core Insights - BeiGene (06160.HK) announced that a total of 62,962 American Depositary Shares (ADS) were purchased by 3,932 participants under the 2018 Employee Stock Purchase Plan during the subscription period from March 3, 2025, to August 29, 2025 [1] - The number of ADS purchased amounts to 818,506, representing approximately 0.05% of the total issued shares of the company as of the date of the announcement [1]